Boon-Cher Goh

3.7k total citations
57 papers, 2.6k citations indexed

About

Boon-Cher Goh is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Boon-Cher Goh has authored 57 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 30 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Boon-Cher Goh's work include Pharmacogenetics and Drug Metabolism (10 papers), Cancer therapeutics and mechanisms (7 papers) and Cancer Treatment and Pharmacology (7 papers). Boon-Cher Goh is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Cancer therapeutics and mechanisms (7 papers) and Cancer Treatment and Pharmacology (7 papers). Boon-Cher Goh collaborates with scholars based in Singapore, China and United States. Boon-Cher Goh's co-authors include Lingzhi Wang, Soo Chin Lee, Nicholas Syn, Edward Kai‐Hua Chow, Chwee Teck Lim, Ross A. Soo, How-Sung Lee, Xiaoqiang Xiang, Sing‐Huang Tan and Andrea Li‐Ann Wong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Boon-Cher Goh

57 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boon-Cher Goh Singapore 25 1.3k 978 771 503 262 57 2.6k
Tristan M. Sissung United States 30 1.2k 0.9× 1.4k 1.4× 506 0.7× 635 1.3× 432 1.6× 94 2.9k
Xiangdong Cheng China 28 1.8k 1.3× 1.0k 1.0× 819 1.1× 572 1.1× 86 0.3× 133 3.1k
Linda Janisch United States 23 1.7k 1.3× 2.1k 2.2× 400 0.5× 738 1.5× 358 1.4× 68 3.6k
Marzia Del Re Italy 34 1.5k 1.1× 1.6k 1.7× 1.3k 1.7× 1.6k 3.2× 140 0.5× 167 3.9k
Dona Alberti United States 30 1.4k 1.0× 1.0k 1.1× 387 0.5× 419 0.8× 77 0.3× 90 2.8k
Jennifer B. Dennison United States 21 1.3k 1.0× 583 0.6× 1.0k 1.3× 237 0.5× 216 0.8× 52 2.1k
Shuiying Hu United States 32 1.3k 1.0× 1.7k 1.7× 255 0.3× 311 0.6× 313 1.2× 94 3.5k
Lacey E. Dobrolecki United States 21 1.4k 1.1× 891 0.9× 412 0.5× 245 0.5× 74 0.3× 53 2.3k
Maja J.A. de Jonge Netherlands 33 1.7k 1.3× 1.5k 1.5× 267 0.3× 620 1.2× 122 0.5× 107 3.1k
Stijn L.W. Koolen Netherlands 25 545 0.4× 1.1k 1.1× 253 0.3× 755 1.5× 171 0.7× 155 2.3k

Countries citing papers authored by Boon-Cher Goh

Since Specialization
Citations

This map shows the geographic impact of Boon-Cher Goh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boon-Cher Goh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boon-Cher Goh more than expected).

Fields of papers citing papers by Boon-Cher Goh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boon-Cher Goh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boon-Cher Goh. The network helps show where Boon-Cher Goh may publish in the future.

Co-authorship network of co-authors of Boon-Cher Goh

This figure shows the co-authorship network connecting the top 25 collaborators of Boon-Cher Goh. A scholar is included among the top collaborators of Boon-Cher Goh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boon-Cher Goh. Boon-Cher Goh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaoguang, et al.. (2024). Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges. Cancers. 16(19). 3300–3300. 19 indexed citations
2.
Okabe, Atsushi, Masato Mima, Masaki Fukuyo, et al.. (2024). Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma. EBioMedicine. 102. 105057–105057. 9 indexed citations
3.
Yong, Wei Peng, Raghav Sundar, Soo Chin Lee, et al.. (2023). Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials. British Journal of Cancer. 128(8). 1514–1520. 2 indexed citations
4.
You, Ming, Shing Leng Chan, Gautam Sethi, et al.. (2022). Clinical translation of patient-derived tumour organoids- bottlenecks and strategies. Biomarker Research. 10(1). 10–10. 54 indexed citations
5.
Li, Juan, Guo Zhang, Chenguang Liu, et al.. (2021). The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy. Theranostics. 12(1). 87–104. 75 indexed citations
6.
Xiang, Xiaoqiang, Manoj Garg, Minh T. N. Le, et al.. (2020). The double-edged sword of H19 lncRNA: Insights into cancer therapy. Cancer Letters. 500. 253–262. 66 indexed citations
7.
Chong, Qing-Yun, Xiaoqiang Xiang, Andrea Li‐Ann Wong, et al.. (2020). A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib. Pharmacological Research. 156. 104686–104686. 79 indexed citations
8.
Li, Boheng, Junli Yan, Tae‐Hoon Chung, et al.. (2019). MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma. Blood. 134(23). 2046–2058. 29 indexed citations
9.
Lee, Matilda, Jayshree L. Hirpara, Gautam Sethi, et al.. (2018). Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors. Redox Biology. 25. 101073–101073. 104 indexed citations
10.
Yu, F., Yanan Lu, Lin Tao, et al.. (2017). Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditions. Scientific Reports. 7(1). 17359–17359. 18 indexed citations
11.
Syn, Nicholas, Lingzhi Wang, Edward Kai‐Hua Chow, Chwee Teck Lim, & Boon-Cher Goh. (2017). Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges. Trends in biotechnology. 35(7). 665–676. 355 indexed citations
12.
Soo, Ross A., Nicholas Syn, Soo Chin Lee, et al.. (2016). Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours. Scientific Reports. 6(1). 27826–27826. 15 indexed citations
13.
Syn, Nicholas, Wei Peng Yong, Soo Chin Lee, & Boon-Cher Goh. (2015). Genetic factors affecting drug disposition in Asian cancer patients. Expert Opinion on Drug Metabolism & Toxicology. 11(12). 1879–1892. 19 indexed citations
14.
Wang, Lingzhi, Winnie Yeo, Jieying Amelia Lau, et al.. (2014). Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients. PLoS ONE. 9(1). 1 indexed citations
15.
Novotny‐Diermayr, Veronica, Nina Sausgruber, Yung Kiang Loh, et al.. (2011). Pharmacodynamic Evaluation of the Target Efficacy of SB939, an Oral HDAC Inhibitor with Selectivity for Tumor Tissue. Molecular Cancer Therapeutics. 10(7). 1207–1217. 19 indexed citations
16.
Wang, Lingzhi, et al.. (2011). Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography–tandem mass spectrometry. Journal of Chromatography A. 1 indexed citations
17.
Wang, Lingzhi, et al.. (2011). Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 61. 86–92. 59 indexed citations
18.
Zhou, Jianbiao, Boon-Cher Goh, Daniel H. Albert, & Chien-Shing Chen. (2009). ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside. Journal of Hematology & Oncology. 2(1). 33–33. 52 indexed citations
19.
Wang, Lingzhi, Ross A. Soo, How-Sung Lee, et al.. (2008). Does saturable formation of gemcitabine triphosphate occur in patients?. Cancer Chemotherapy and Pharmacology. 63(1). 55–64. 16 indexed citations
20.
Wang, Lingzhi, Boon-Cher Goh, How-Sung Lee, Paul Noordhuis, & Godefridus J. Peters. (2003). An Expedient Assay for Determination of Gemcitabine and Its Metabolite in Human Plasma Using Isocratic Ion-Pair Reversed-Phase High-Performance Liquid Chromatography. Therapeutic Drug Monitoring. 25(5). 552–557. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tristan M. Sissung Breakdown of academic impact, for papers by Xiangdong Cheng Breakdown of academic impact, for papers by Linda Janisch Breakdown of academic impact, for papers by Marzia Del Re Breakdown of academic impact, for papers by Dona Alberti Breakdown of academic impact, for papers by Jennifer B. Dennison Breakdown of academic impact, for papers by Shuiying Hu Breakdown of academic impact, for papers by Lacey E. Dobrolecki Breakdown of academic impact, for papers by Maja J.A. de Jonge Breakdown of academic impact, for papers by Stijn L.W. Koolen
Rankless by CCL
2026